Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Danny Idryo"'
Autor:
Guillermo Garcia-Manero, Rayna K. Matsuno, Ali Mcbride, Adeola Y Makinde, Thomas D. Brown, Danny Idryo, Ronda Broome, Autumn Herriman, Kristiana Wilkinson, Sheetal Walters, Andrew Schrag, Hina Mohammed, Monika A. Izano, Sudipto Mukherjee
Publikováno v:
HemaSphere, Vol 7, p e20066a9 (2023)
Externí odkaz:
https://doaj.org/article/9bceb06cd56d4794a5b7e37324d5d685
Autor:
Monika A. Izano, Nguyet Tran, Alan Fu, Liz Toland, Danny Idryo, Ryan Hilbelink, Huakang Tu, Hil Hsu, Chris Sommers, Matthew Rioth, Thomas Brown
Publikováno v:
Clinical Lung Cancer. 23:191-194
To accelerate drug approvals while maintaining scientific rigor in the evaluation of a therapeutic's efficacy and safety, the United States Food and Drug Administration now considers real-world data (RWD) to support New Drug Applications and expanded
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8f6dfcad5547a30f17f2ef5b6993d2c
https://doi.org/10.1016/j.cllc.2022.01.002
https://doi.org/10.1016/j.cllc.2022.01.002
Autor:
Guillermo Garcia-Manero, Rayna K. Matsuno, Ali McBride, Thomas D. Brown, Danny Idryo, Ronda Broome, Autumn Herriman, Tiffany Johnson, Kristiana Wilkinson, Sheetal Walters, Andrew Schrag, Colden Johanson, Monika A. Izano, Sudipto Mukherjee
Publikováno v:
Journal of Clinical Oncology. 40:e19067-e19067
e19067 Background: The median survival for pts with LR-MDS is estimated to be 5–10 years. ESAs are utilized as first-line treatment for anemia in LR-MDS; however, real-world treatment patterns, clinical outcomes, and HCRU for pts with LR-MDS who re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be181a35b11378b5ad1fc010afff59f0
https://doi.org/10.1200/jco.2022.40.16_suppl.e19067
https://doi.org/10.1200/jco.2022.40.16_suppl.e19067
Publikováno v:
Journal of Clinical Oncology. 40:1555-1555
1555 Background: It is a challenge to identify patients with myelodysplastic syndrome (MDS) using structured data from electronic health records (EHRs). Current claims-based algorithms incorporating diagnosis codes, clinical labs, and procedures have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ee2903d54a2989e5224ef05c1d325c0
https://doi.org/10.1200/jco.2022.40.16_suppl.1555
https://doi.org/10.1200/jco.2022.40.16_suppl.1555